Paul F. Truex, President and CEO at Anthera Pharmaceuticals Inc (ANTH), sold 23,235 shares at $6.25 ($145K) on 2011-10-21, disclosed to the SEC on 2011-10-25.
Scheduled sale ($145k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.25 | 11,356 | $71K | 48.9% |
| 2 | $6.25 | 11,879 | $74K | 51.1% |
| Total | $6.25 avg | 23,235 | $145K | 100% |
| Filing → |
| ANTH | BUY | 2012-07-02 | $15K | — | Filing → |
| ANTH | SELL | 2012-02-17 | $118K | — | Filing → |
| ANTH | SELL | 2012-01-19 | $101K | — | Filing → |